Baldwin Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.47M | Buy |
14,541
+711
| +5% | +$317K | 0.78% | 13 |
|
|
2025
Q1 | $6.71M | Buy |
13,830
+1,271
| +10% | +$616K | 0.81% | 13 |
|
|
2024
Q4 | $5.06M | Buy |
12,559
+668
| +6% | +$269K | 0.66% | 16 |
|
|
2024
Q3 | $5.53M | Buy |
11,891
+135
| +1% | +$62.8K | 0.69% | 18 |
|
|
2024
Q2 | $5.51M | Buy |
11,756
+1,407
| +14% | +$659K | 0.75% | 16 |
|
|
2024
Q1 | $4.33M | Buy |
10,349
+976
| +10% | +$408K | 0.59% | 20 |
|
|
2023
Q4 | $3.81M | Buy |
9,373
+347
| +4% | +$141K | 0.6% | 25 |
|
|
2023
Q3 | $3.14M | Buy |
9,026
+533
| +6% | +$185K | 0.52% | 28 |
|
|
2023
Q2 | $2.99M | Buy |
8,493
+130
| +2% | +$45.7K | 0.49% | 32 |
|
|
2023
Q1 | $2.63M | Buy |
8,363
+52
| +0.6% | +$16.4K | 0.47% | 37 |
|
|
2022
Q4 | $2.4M | Buy |
8,311
+535
| +7% | +$154K | 0.43% | 41 |
|
|
2022
Q3 | $2.25K | Buy |
7,776
+259
| +3% | +$75 | 0.46% | 36 |
|
|
2022
Q2 | $2.12K | Sell |
7,517
-99
| -1% | -$28 | 0.4% | 43 |
|
|
2022
Q1 | $1.99K | Buy |
7,616
+917
| +14% | +$239 | 0.3% | 57 |
|
|
2021
Q4 | $1.47K | Buy |
6,699
+649
| +11% | +$143 | 0.23% | 80 |
|
|
2021
Q3 | $1.1M | Sell |
6,050
-55
| -0.9% | -$9.97K | 0.19% | 92 |
|
|
2021
Q2 | $1.23M | Buy |
6,105
+240
| +4% | +$48.4K | 0.21% | 85 |
|
|
2021
Q1 | $1.26M | Buy |
+5,865
| New | +$1.26M | 0.23% | 81 |
|